Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation

NMP Medical Research Institute22 enrolled

Overview

The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

The COVID-19 related lockdowns severely affected the healthcare in India, specially in second wave of COVID-19. This research presents the applicability of Ayurveda formulation to analyze the impact on lipid profile during the lockdown. Patients with hyperlipidemia who referred to Gyansanjeevani were recruited. All participants were enrolled in the study after a complete physical examination and medical history remotely over the virtual secure platform.

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

Conditions

Hypercholesterolemia

Interventions

Cardio-complementCOMBINATION_PRODUCT

Ayurvedic combination of Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer) in pre-specified dosage.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 18 and 65 years * BMI between 18.5 and 40 kg/m2 * Total Cholesterol \>180 mg/dl * No clinically significant medical history * Willing to participate to the study by complying with the protocol * Able to provide written informed consent Exclusion Criteria: * Metabolic disorder such as diabetes, uncontrolled thyroidal trouble or other metabolic disorder, * Severe chronic disease * History of ischemic cardiovascular event, * Uncontrolled hypertension * Under treatment or dietary supplement which could affect study parameter

Locations (1)

Gyansanjeevani

Jaipur, Rajasthan, India

Outcomes

Primary Outcomes

Reduction of LDL-cholesterol

Time frame: Change from baseline to 2 weeks

Secondary Outcomes

Reduction of total cholesterol

Time frame: Changes from baseline to 2 weeks

Increase of HDL cholesterol

Time frame: Change from baseline to 2 weeks

Reduction of Triglycerides

Time frame: Change from baseline to 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.